NewsCase StudiesEvents

GlaxoSmithKline investing in Greece

Also in the news...

UAE and UK conclude bilateral visit to strengthen partnership against illicit finance

Joint statement on strengthening UK-United Arab Emirates (UAE) partnership against illicit finance following a bilateral visit.

Strategic Partnership UK-Moldova , Trade and Cooperation Agreement

Documents containing treaty information and a summary of the UK-Moldova trade agreement.

Create a goods movement reference

Get a goods movement reference to move goods through locations which use the Goods Vehicle Movement Service.

Israel export control licensing data: 31 July 2025

Export control licensing management information for Israel

Trade and services regulations in Luxembourg

If you are a UK business providing services in Luxembourg, you will need to follow Luxembourg regulations about:

GlaxoSmithKline investing in Greece

Back to News

The leading UK pharmaceutical company, Glaxo Smithkline (GSK) announced new €2.2 million investment in Greece, at the British Residence.

This investment will enable secondary packaging for 4 over-the-counter products. This will take place at FAMAR’s facilities, in the context of a long-term cooperation between the two companies. Production is expected to begin before the end of the year and will reinforce the exporting capacity of GSK Greece, as 98% of the new production will be exported to 32 countries.

The Minister for Development, Costis Hatzidakis, opened the event alongside the host, the British Ambassador, John Kittmer, who said:

I am delighted that GSK, a great British company, has decided to increase its investment in Greece. This decision shows the importance of foreign direct investment to Greece’s future and the importance of Greece’s efforts to improve the business environment.

gov.uk

You are not logged in!

Please login or register to ask our experts a question.

Login now or register.